Clinical Trials

Clinical Trials Overview

This section contains current information about ongoing clinical development programs sponsored by Myriad Pharmaceuticals, Inc. For more detailed information, please see the specific drug sections as they become available.

Molecule Therapeutic Area Development Stage
Azixa™ (MPC-6827) Melanoma Phase 2 Ongoing
Azixa Glioblastoma multiforme (GBM) Phase 2 Recruiting
Azixa GBM (monotherapy) Phase 2 Recruiting
MPC-3100 Cancer Phase 1 Recruiting
MPC-4326 HIV Infection Phase 2 Initiating

For more information on our Azixa™(MPC-6827) clinical studies in brain cancer, please visit our new website designed to answer your questions